Overt immediate hemolytic transfusion reaction attributable to anti-Wra
24 mar 2020
O artykule
Kategoria artykułu: Case Report
Data publikacji: 24 mar 2020
Zakres stron: 113 - 115
DOI: https://doi.org/10.21307/immunohematology-2019-282
Słowa kluczowe
© 2008 F.N. Boctor, published by Sciendo
Wra is a low-prevalence antigen. Anti-Wra is a relatively common antibody present in approximately 1 in 100 healthy blood donors. Anti-Wra is reported to cause different degrees of hemolysis in transfusion and in HDN, ranging from benign to severe. This report describes an acute overt hemolytic transfusion reaction in a patient whose serum contained anti-Wra and who received a Wr(a+) RBC component.